You have 9 free searches left this month | for more free features.

phosphodiesterase-5 inhibitor

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

MDD Trial in Shibin Al Kawm (Sildenafil Citrate, Placebo oral tablet)

Recruiting
  • Major Depressive Disorder
  • Sildenafil Citrate
  • Placebo oral tablet
  • Shibīn Al Kawm, Egypt
    Faculty of Medicine
Jan 16, 2023

Congenital Diaphragmatic Hernia, Pulmonary Hypertension Trial in Salt Lake City (Sildenafil Oral Suspension, Placebo)

Not yet recruiting
  • Congenital Diaphragmatic Hernia
  • Pulmonary Hypertension
  • Sildenafil Oral Suspension
  • Placebo
  • Salt Lake City, Utah
    Primary Children's Hospital
Jan 27, 2022

Erectile Dysfunction, Sexual Dysfunction Trial in Salt Lake City (Natesto Nasal Product, Placebo)

Recruiting
  • Erectile Dysfunction
  • Sexual Dysfunction
  • Natesto Nasal Product
  • Placebo
  • Salt Lake City, Utah
    University of Utah, Division of Urology
Aug 11, 2022

Phosphodiesterase Type 5 Inhibitor to Improve Anabolic

Not yet recruiting
  • Sarcopenia
  • Tadalafil 5mg
  • Little Rock, Arkansas
    University of Arkansas for Medical Sciences
Jul 25, 2022

MDD Trial in Shibin Al Kawm (Tadalafil 5Mg Tab, Placebo)

Recruiting
  • Major Depressive Disorder
  • Tadalafil 5Mg Tab
  • Placebo
  • Shibīn Al Kawm, Menoufia, Egypt
    Faculty of Pharmacy
Aug 31, 2021

Erectile Dysfunction Following Radiation Therapy, Phosphodiesterase Inhibitor Adverse Reaction, Platelet- Rich Plasma (PRP)

Active, not recruiting
  • Erectile Dysfunction Following Radiation Therapy
  • +2 more
  • P shot arm ( Autologous Platelet Rich Plasma)
  • PDE5i arm
  • Mansoura, Outside U.S./Canada, Egypt
    Mansoura urology and nephrology center
Mar 15, 2023

Sickle Cell People With Pulmonary Hypertension

Completed
  • Pulmonary Hypertension
  • Sickle Cell Disease
    • Bethesda, Maryland
      National Heart, Lung and Blood Institute (NHLBI)
    Apr 16, 2021

    Post-Traumatic Headache Trial (Sildenafil, Placebo)

    Not yet recruiting
    • Post-Traumatic Headache
    • (no location specified)
    Dec 20, 2022

    MDD Trial in Shibeen Elkom (Roflumilast 250Mcg Tab, Placebo)

    Recruiting
    • Major Depressive Disorder
    • Roflumilast 500Mcg Tab
    • Placebo
    • Shibeen Elkom, Menoufia, Egypt
      Faculty of Pharmacy
    Jan 16, 2023

    Asthma Trial in Sacramento (Roflumilast, Placebo)

    Recruiting
    • Asthma
    • Sacramento, California
      UC Davis
    Jan 31, 2022

    Osteoarthritis Trial in Shibin Al Kawm (Cilostazol 50 MG, Placebo)

    Recruiting
    • Osteoarthritis
    • Cilostazol 50 MG
    • Placebo
    • Shibīn Al Kawm, Menoufia, Egypt
      Faculty of Pharmacy
    Jul 28, 2022

    Schizophrenia Trial in Shibin Al Kawm (Placebo oral tablet, Pentoxifylline)

    Completed
    • Schizophrenia
    • Shibīn Al Kawm, Egypt
      Faculty of Medicine
    Oct 23, 2022

    Carotid Artery Intima Media Thickness Can Predict Response to

    Completed
    • Erectile Dysfunction Due to Arterial Disease
    • CIMT (Carotid artery intima media thickness measurement)
    • Bursa, Turkey
      Bursa Yuksek Ihtisas Training and Research Hospital
    Jan 11, 2023

    Metastatic Colorectal Cancer, Cetuximab, Skin Toxicity Trial in Guangzhou (Crisaborole Ointment, Cetuximab)

    Recruiting
    • Metastatic Colorectal Cancer
    • +2 more
    • Guangzhou, Guangdong, China
      WeiWei Xiao
    Nov 3, 2023

    Rheumatoid Arthritis Trial (Cilostazol, Methotrexate, Placebo)

    Not yet recruiting
    • Rheumatoid Arthritis
    • (no location specified)
    Oct 30, 2022

    Benign Prostatic Hyperplasia Trial (Phosphodiesterase 5 Inhibitors, Alpha Blockers, Combined Alpha Blockers and

    Not yet recruiting
    • Benign Prostatic Hyperplasia
    • Phosphodiesterase 5 Inhibitors
    • +2 more
    • (no location specified)
    Feb 10, 2022

    Single-ventricle, Pulmonary Hypertension, Univentricular Heart Trial (Sildenafil, Placebos)

    Not yet recruiting
    • Single-ventricle
    • +2 more
    • (no location specified)
    Jan 20, 2022

    COPD Exacerbation, Enoximone, Phosphodiesterase Inhibitor Trial in Arnhem (Enoximone)

    Terminated
    • COPD Exacerbation
    • +2 more
    • Arnhem, M, Netherlands
      M.V. Koning
    Dec 23, 2021

    Fundus Oculi and Erectile Dysfunction

    Unknown status
    • Erectile Dysfunction
    • Dynamic Vessel Analyzer (DVA)
    • Phosphodiesterase type 5 Inhibitor (PDE5I)
    • Milan, MI, Italy
      Ospedale San Raffaele
    Jul 20, 2020

    Pulmonary Hypertension, COPD Trial (Tadalafil)

    Not yet recruiting
    • Pulmonary Hypertension
    • Chronic Obstructive Pulmonary Disease
    • (no location specified)
    Apr 25, 2023

    Neuromyelitis Optica Spectrum Disorder, NMOSD, AQP4+ NMOSD Trial

    Not yet recruiting
    • Neuromyelitis Optica Spectrum Disorder
    • +2 more
      • (no location specified)
      Jul 21, 2023

      Diabetes, Type 2 Trial in Gothenburg (Tadalafil, Placebo)

      Completed
      • Diabetes Mellitus, Type 2
      • Gothenburg, Sweden
        Sahlgrenska University Hospital
      Feb 10, 2020

      Alcohol, Phosphodiesterase Inhibitor, Erectile Dysfunction Trial in Shanghai (TPN171H tablet plus alcohol, alcohol, TPN171H

      Completed
      • Alcohol
      • +2 more
      • TPN171H tablet plus alcohol
      • +2 more
      • Shanghai, China
        Shanghai Xuhui Central Hospital
      May 20, 2022

      Erectile Dysfunction Trial in Saint Petersburg (PDE5 inhibitor (tadalafil) and BTL-6000 fSWT, PDE5 inhibitor (tadalafil))

      Recruiting
      • Erectile Dysfunction
      • PDE5 inhibitor (tadalafil) and BTL-6000 fSWT
      • PDE5 inhibitor (tadalafil)
      • Saint Petersburg, Russian Federation
        SBPSU
      Apr 10, 2023

      Heart Defects, Congenital, Transposition of Great Vessels With Ventricular Inversion Trial in Austria, Switzerland (Tadalafil 20

      Completed
      • Heart Defects, Congenital
      • Transposition of Great Vessels With Ventricular Inversion
      • Tadalafil 20 MG
      • Placebo 20 MG
      • Wien, Austria
      • +6 more
      Feb 23, 2022